Management and Prevention of Recurrent Cellulitis

Introduction to Management

For patients experiencing 3-4 episodes of cellulitis per year despite addressing predisposing factors, prophylactic antibiotics with oral penicillin or erythromycin 250 mg twice daily for 4-52 weeks, or intramuscular benzathine penicillin 1.2 million units every 2-4 weeks, should be initiated and continued as long as predisposing factors persist, as recommended by the Infectious Diseases Society of America 1

When treating an acute recurrence of cellulitis, antibiotic selection should include agents active against streptococci, such as penicillin, amoxicillin, cephalexin, or clindamycin, with a treatment duration of 5 days, which can be extended if the infection has not improved, based on guidelines from the Infectious Diseases Society of America 2
The affected limb should be elevated to promote gravity drainage of edema and inflammatory substances, as suggested by the Clinical Infectious Diseases journal 3, 1

Critical predisposing factors to identify and treat include lymphedema and chronic venous insufficiency, which can be managed with limb elevation, compression stockings, pneumatic pressure pumps, and diuretic therapy when appropriate, as recommended by the American College of Phlebology 3, 1
Interdigital maceration and tinea pedis should be treated aggressively with antifungal agents and enhanced foot hygiene, as suggested by the Infectious Diseases Society of America 3, 1
Skin barrier dysfunction should be addressed by keeping the skin well-hydrated with daily emollients to prevent dryness and cracking, based on guidelines from the American Academy of Dermatology 3
Obesity should be managed through weight reduction, as recommended by the American Heart Association 1

Prophylaxis should only be considered after predisposing factors have been addressed, as each cellulitis episode causes lymphatic damage that increases future risk, according to the Clinical Infectious Diseases journal 3
Indications for prophylaxis include 3-4 episodes per year despite management of predisposing factors, with annual recurrence rates reaching 8-20% in high-risk patients, as reported by the Infectious Diseases Society of America 1
Prophylactic regimen options include oral penicillin V 1 gram twice daily, erythromycin 250 mg twice daily, or intramuscular benzathine penicillin 1.2 million units every 2-4 weeks, with a duration of 4-52 weeks, continued as long as predisposing factors persist, as recommended by the American College of Cardiology 1

Corticosteroids, such as prednisone 40 mg daily for 7 days, can be considered to reduce inflammation and hasten resolution in non-diabetic adult patients, although this is a weak recommendation, based on guidelines from the Infectious Diseases Society of America 1

Failing to address predisposing factors can lead to lymphatic inflammation and permanent damage, with severe or repeated episodes resulting in lymphedema, as reported by the Clinical Infectious Diseases journal 3
Discontinuing prophylaxis prematurely can lead to recurrence, and prophylaxis should be continued as long as predisposing factors persist, as recommended by the Infectious Diseases Society of America 1
Overlooking simple measures, such as elevation and emollients, can neglect critical aspects of management, according to the American Academy of Dermatology 3
Using unnecessarily broad antibiotics can be avoided by targeting streptococci, the primary pathogen in recurrent cellulitis, as suggested by the Infectious Diseases Society of America 2